INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 99 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 2.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $85,705 | -56.0% | 25,060 | -32.4% | 0.00% | 0.0% |
| Q1 2016 | $195,000 | -33.0% | 37,083 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $291,000 | -3.6% | 37,083 | +3.8% | 0.00% | 0.0% |
| Q3 2015 | $302,000 | -23.9% | 35,720 | -1.4% | 0.00% | -33.3% |
| Q2 2015 | $397,000 | -26.8% | 36,229 | -6.5% | 0.00% | -25.0% |
| Q1 2015 | $542,000 | -17.1% | 38,742 | 0.0% | 0.00% | -20.0% |
| Q4 2014 | $654,000 | +25.8% | 38,742 | 0.0% | 0.01% | +25.0% |
| Q3 2014 | $520,000 | +5.3% | 38,742 | 0.0% | 0.00% | +33.3% |
| Q2 2014 | $494,000 | +7.2% | 38,742 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $461,000 | -13.8% | 38,742 | 0.0% | 0.00% | -25.0% |
| Q4 2013 | $535,000 | -20.9% | 38,742 | 0.0% | 0.00% | -20.0% |
| Q3 2013 | $676,000 | +7.3% | 38,742 | 0.0% | 0.01% | 0.0% |
| Q2 2013 | $630,000 | – | 38,742 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,100,000 | $14,762,000 | 6.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,882,805 | $52,107,000 | 1.90% |
| Cheyne Capital Management (UK) LLP | 326,821 | $4,388,000 | 1.56% |
| BB BIOTECH AG | 2,320,737 | $31,144,000 | 1.27% |
| Broadfin Capital, LLC | 854,384 | $11,466,000 | 1.20% |
| HealthCor Management, L.P. | 1,162,200 | $15,597,000 | 0.80% |
| Orbimed Advisors | 4,736,900 | $63,569,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 148,000 | $1,986,000 | 0.58% |
| SOUND ENERGY PARTNERS, INC. | 51,000 | $684,000 | 0.53% |
| Rock Springs Capital Management LP | 210,000 | $2,818,000 | 0.44% |